Edition:
United Kingdom

People: Cutera Inc (CUTR.OQ)

CUTR.OQ on NASDAQ Stock Exchange Global Select Market

30.60USD
20 Sep 2018
Change (% chg)

-- (--)
Prev Close
$30.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
57,568
52-wk High
$56.05
52-wk Low
$30.05

Reinstein, James 

Mr. James A. Reinstein is the President, Chief Executive Officer, Director of Cutera Inc. Prior to joining Cutera, Mr. Reinstein served as the CEO of Drawbridge Health Inc., a joint venture of GE Ventures and GE Healthcare. Prior to Drawbridge, He was the CEO of Aptus Endosystems from 2012 until its acquisition by Medtronic in 2015. From 2007-2012, he was the EVP and Chief Commercial Officer of Cyberonics, Inc. At Cyberonics, Mr. Reinstein drove the strategy for many of its departments including Research & Development, Clinical Research, and New Business Development and led a global commercial team of over 200 employees, growing revenues by 250% within three years. Prior to Cyberonics, Mr. Reinstein held a variety of management positions of increasing responsibility within Boston Scientific Corporation from 1990-2007, including Vice President and Regional Head of an Asian business unit; Country Director of Boston Scientific de Mexico; and European Head for its Neurovascular Division. He began his career with Proctor & Gamble.

Basic Compensation

Total Annual Compensation, USD 839,772
Restricted Stock Award, USD 5,422,940
Long-Term Incentive Plans, USD --
All Other, USD 2,019
Fiscal Year Total, USD 6,264,730

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --